Norbert G. Riedel, Director at Jazz Pharmaceuticals plc (JAZZ), sold 3,415 shares at $192.00 ($656K) on 2026-02-27, disclosed to the SEC on 2026-03-02.
Open-market sale of $656k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APTX | BUY | 2021-12-08 | $223K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |
| JAZZ | SELL | 2020-08-10 | $234K | — | Filing → |